Men with IGF-I levels >113 ng ml−1 were 59% less likely to develop kidney cancer than men with levels ⩽113 ng ml−1 (odds ratio=0.41; 95% confidence interval=0.23–0.75). The gene discussed is IGF1; the disease is kidney cancer.